Heart Failure Care in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis
Background:
Heart failure places a significant burden on patients and health systems in high-income countries. However, information about its burden in low- and middle-income countries (LMICs) is scant. We thus set out to review both published and unpublished information on the presentation, causes, management, and outcomes of heart failure in LMICs.
Methods and Findings:
Medline, Embase, Global Health Database, and World Health Organization regional databases were searched for studies from LMICs published between 1 January 1995 and 30 March 2014. Additional unpublished data were requested from investigators and international heart failure experts. We identified 42 studies that provided relevant information on acute hospital care (25 LMICs; 232,550 patients) and 11 studies on the management of chronic heart failure in primary care or outpatient settings (14 LMICs; 5,358 patients). The mean age of patients studied ranged from 42 y in Cameroon and Ghana to 75 y in Argentina, and mean age in studies largely correlated with the human development index of the country in which they were conducted (r = 0.71, p<0.001). Overall, ischaemic heart disease was the main reported cause of heart failure in all regions except Africa and the Americas, where hypertension was predominant. Taking both those managed acutely in hospital and those in non-acute outpatient or community settings together, 57% (95% confidence interval [CI]: 49%–64%) of patients were treated with angiotensin-converting enzyme inhibitors, 34% (95% CI: 28%–41%) with beta-blockers, and 32% (95% CI: 25%–39%) with mineralocorticoid receptor antagonists. Mean inpatient stay was 10 d, ranging from 3 d in India to 23 d in China. Acute heart failure accounted for 2.2% (range: 0.3%–7.7%) of total hospital admissions, and mean in-hospital mortality was 8% (95% CI: 6%–10%). There was substantial variation between studies (p<0.001 across all variables), and most data were from urban tertiary referral centres. Only one population-based study assessing incidence and/or prevalence of heart failure was identified.
Conclusions:
The presentation, underlying causes, management, and outcomes of heart failure vary substantially across LMICs. On average, the use of evidence-based medications tends to be suboptimal. Better strategies for heart failure surveillance and management in LMICs are needed.
Please see later in the article for the Editors' Summary
Vyšlo v časopise:
Heart Failure Care in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis. PLoS Med 11(8): e32767. doi:10.1371/journal.pmed.1001699
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001699
Souhrn
Background:
Heart failure places a significant burden on patients and health systems in high-income countries. However, information about its burden in low- and middle-income countries (LMICs) is scant. We thus set out to review both published and unpublished information on the presentation, causes, management, and outcomes of heart failure in LMICs.
Methods and Findings:
Medline, Embase, Global Health Database, and World Health Organization regional databases were searched for studies from LMICs published between 1 January 1995 and 30 March 2014. Additional unpublished data were requested from investigators and international heart failure experts. We identified 42 studies that provided relevant information on acute hospital care (25 LMICs; 232,550 patients) and 11 studies on the management of chronic heart failure in primary care or outpatient settings (14 LMICs; 5,358 patients). The mean age of patients studied ranged from 42 y in Cameroon and Ghana to 75 y in Argentina, and mean age in studies largely correlated with the human development index of the country in which they were conducted (r = 0.71, p<0.001). Overall, ischaemic heart disease was the main reported cause of heart failure in all regions except Africa and the Americas, where hypertension was predominant. Taking both those managed acutely in hospital and those in non-acute outpatient or community settings together, 57% (95% confidence interval [CI]: 49%–64%) of patients were treated with angiotensin-converting enzyme inhibitors, 34% (95% CI: 28%–41%) with beta-blockers, and 32% (95% CI: 25%–39%) with mineralocorticoid receptor antagonists. Mean inpatient stay was 10 d, ranging from 3 d in India to 23 d in China. Acute heart failure accounted for 2.2% (range: 0.3%–7.7%) of total hospital admissions, and mean in-hospital mortality was 8% (95% CI: 6%–10%). There was substantial variation between studies (p<0.001 across all variables), and most data were from urban tertiary referral centres. Only one population-based study assessing incidence and/or prevalence of heart failure was identified.
Conclusions:
The presentation, underlying causes, management, and outcomes of heart failure vary substantially across LMICs. On average, the use of evidence-based medications tends to be suboptimal. Better strategies for heart failure surveillance and management in LMICs are needed.
Please see later in the article for the Editors' Summary
Zdroje
1. MosterdA, HoesAW (2007) Clinical epidemiology of heart failure. Heart 93: 1137–1146 doi:10.1136/hrt.2003.025270
2. BuiAL, HorwichTB, FonarowGC (2011) Epidemiology and risk profile of heart failure. Nat Rev Cardiol 8: 30–41 doi:10.1038/nrcardio.2010.165
3. HobbsFDR, RoalfeAK, DavisRC, DaviesMK, HareR (2007) Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES). Eur Heart J 28: 1128–1134 doi:10.1093/eurheartj/ehm102
4. LevyD, KenchaiahS, LarsonMG, BenjaminEJ, KupkaMJ, et al. (2002) Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347: 1397–1402 doi:10.1056/NEJMoa020265
5. RogerVL, GoAS, Lloyd-JonesDM, AdamsRJ, BerryJD, et al. (2011) Heart disease and stroke statistics–2011 update: a report from the American Heart Association. Circulation 123: e18–e209 doi:10.1161/CIR.0b013e3182009701
6. National Institute for Cardiovascular Outcomes Research (2011) National heart failure audit: April 2010–March 2011. London: University College London. Available: http://www.hqip.org.uk/assets/NCAPOP-Library/Heart-Failure-Audit-Report-NICOR-2010-2011.pdf. Accessed 21 July 2014.
7. JencksSF, WilliamsMV, ColemanEA (2009) Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 360: 1418–1428 doi:10.1056/NEJMsa0803563
8. ZarrinkoubR, WettermarkB, WändellP, MejhertM, SzulkinR, et al. (2013) The epidemiology of heart failure, based on data for 2.1 million inhabitants in Sweden. Eur J Heart Fail 15: 995–1002 doi:10.1093/eurjhf/hft064
9. BleuminkGS, KnetschAM, SturkenboomMCJM, StrausSMJM, HofmanA, et al. (2004) Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. Eur Heart J 25: 1614–1619 doi:10.1016/j.ehj.2004.06.038
10. LozanoR, NaghaviM, ForemanK, LimS, ShibuyaK, et al. (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2095–2128 doi:10.1016/S0140-6736(12)61728-0
11. MurrayCJL, VosT, LozanoR, NaghaviM, FlaxmanAD, et al. (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2197–2223 doi:10.1016/S0140-6736(12)61689-4
12. MendezGF, CowieMR (2001) The epidemiological features of heart failure in developing countries: a review of the literature. Int J Cardiol 80: 213–219.
13. MoherD, LiberatiA, TetzlaffJ, AltmanDG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6: e1000097 doi:10.1371/journal.pmed.1000097
14. BennettDA, EliaszTK, ForbesA, KiszelyA, KhoslaR, et al. (2012) Study protocol: systematic review of the burden of heart failure in low- and middle-income countries. Syst Rev 1: 59 doi:10.1186/2046-4053-1-59
15. World Bank (2014) World DataBank [database]. Available: http://databank.worldbank.org/data/databases.aspx. Accessed 7 March 2013.
16. Von ElmE, AltmanDG, EggerM, PocockSJ, GotzschePC, et al. (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335: 806–808 doi:10.1136/bmj.39335.541782.AD
17. DerSimonianR, LairdN (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177–188.
18. United Nations Development Programme Human Development Reports (2014) Human Development Index (HDI). Available: http://hdr.undp.org/en/statistics/hdi/. Accessed 17 November 2013.
19. BarrettoACP, Del CarloCH, CardosoJN, MorgadoPC, MunhozRT, et al. (2008) Hospital readmissions and death from heart failure—rates still alarming. Arq Bras Cardiol 91: 309–314.
20. SiswantoB, RadiB, KalimH (2010) Heart failure in NCVC Jakarta and 5 hospitals in Indonesia. CVD Prev Control 5: 35–38 doi:10.1016/j.cvdpc.2010.03.005
21. AmarillaGA, CarballidoR, TacchiCD, FariasEF, PernaER, et al. (1999) Insuficiencia cardiaca en la Republica Argentina. Variables relacionadas con mortalidad intrahospitalaria. Resultados preliminares del protocolo CONAREC VI. Rev Argent Cardiol 67: 53–62.
22. LaabesEP, ThacherTD, OkeahialamBN (2008) Risk factors for heart failure in adult Nigerians. Acta Cardiol 63: 437–443 doi:10.2143/AC.63.4.2033041
23. DíazA, FerranteD, BadraR, MoralesI, BecerraA, et al. (2007) Seasonal variation and trends in heart failure morbidity and mortality in a South American community hospital. Congest Heart Fail 13: 263–266.
24. KingueS, DzudieA, MenangaA, AkonoM, OuankouM, et al. (2005) [A new look at adult chronic heart failure in Africa in the age of the Doppler echocardiography: experience of the medicine department at Yaounde General Hospital]. Ann Cardiol Angéiologie 54: 276–283 doi:10.1016/j.ancard.2005.04.014
25. StewartS, WilkinsonD, HansenC (2008) Predominance of heart failure in the Heart of Soweto Study cohort emerging challenges for urban African communities. Circulation 118: 2360–2367 doi:10.1161/CIRCULATIONAHA.108.786244
26. OjjiDB, AlfaJ, AjayiSO, MamvenMH, FalaseAO (2009) Cardiovascular topics pattern of heart failure in Abuja, Nigeria: an echocardiographic study. Cardiovasc J Afr 20: 349–352.
27. OjjiD, StewartS, AjayiS, ManmakM, SliwaK (2013) A predominance of hypertensive heart failure in the Abuja Heart Study cohort of urban Nigerians: a prospective clinical registry of 1515 de novo cases. Eur J Heart Fail 15: 835–842 doi:10.1093/eurjhf/hft061
28. AdebayoAK, AdebiyiAA, OladapoOO, OgahOS, AjeA, et al. (2009) Characterisation of heart failure with normal ejection fraction in a tertiary hospital in Nigeria. BMC Cardiovasc Disord 9: 52 doi:10.1186/1471-2261-9-52
29. Tantchou TchoumiJC, AmbassaJC, KingueS, GiambertiA, CirriS, et al. (2011) Occurrence, aetiology and challenges in the management of congestive heart failure in sub-Saharan Africa: experience of the Cardiac Centre in Shisong, Cameroon. Pan Afr Med J 8: 11.
30. AmoahAG, KallenC (2000) Aetiology of heart failure as seen from a National Cardiac Referral Centre in Africa. Cardiology 93: 11–18 doi:10.1159/000006996
31. OnwuchekwaAC, AsekomehGE (2009) Pattern of heart failure in a Nigerian teaching hospital. Vasc Heal Risk Manag 5: 745–750.
32. Longo-MbenzaB, MambuneHFA, KasiamJB, VitaEK, FueleSM, et al. (2007) Relationship between waist circumference and cholesterol in central Africans with congestive heart failure. West Afr J Med 26: 183–190.
33. AdedoyinRA, AdesoyeA (2005) Incidence and pattern of cardiovascular disease in a Nigerian teaching hospital. Trop Doct 35: 104–106 doi:10.1258/0049475054037075
34. ChijiokeA, KoloP (2009) Mortality pattern at the adult medical wards of a teaching hospital in sub-Saharan Africa. Int J Trop Med 4: 27–31.
35. DamascenoA, MayosiBM, SaniM, OgahOS, MondoC, et al. (2012) The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries. Arch Intern Med 172: 1386–1394 doi:10.1001/archinternmed.2012.3310
36. OmoleO, OgunbayoOO, FasanmadeAA (2011) A ten year study of management of chronic heart failure in a tertiary hospital in the South West Nigeria. Int J Pharm Technol 3: 1520–1536.
37. AnsaVO, EkottJU, EssienIO, BasseyEO (2008) Seasonal variation in admission for heart failure, hypertension and stroke in Uyo, South-Eastern Nigeria. Ann Afr Med 7: 62–66.
38. ThiamM (2003) Insuffisance cardiaque en milieu cardiologique africain. Bull Soc Pathol Exot 96: 217–218.
39. BalieiroHM, OsugueRK, RangelSP, BrandãoR, BalieiroTL, et al. (2009) Clinical and demographic profile and quality indicators for heart failure in a rural area. Arq Bras Cardiol 93: 637–642.
40. TavaresLR, VicterH, LinharesJM, BarrosCM De, OliveiraMV, et al. (2004) Epidemiology of decompensated heart failure in the city of Niterói: EPICA–Niterói Project. Arq Bras Cardiol 82: 125–128.
41. CastroPG, VukasovicJLR, GarcésES, SepúlvedaLM, FerradaMK, et al. (2004) Insuficiencia cardíaca en hospitales chilenos: resultados del Registro Nacional de Insuficiencia Cardíaca, Grupo ICARO. Rev Med Chile 132: 655–662.
42. De Campos LopesCB, YamadaAT, AraújoF, Pereira BarretoAC, MansurAJ (2006) Socioeconomic factors in the prognosis of heart failure in a Brazilian cohort. Int J Cardiol 113: 181–187 doi:10.1016/j.ijcard.2005.11.009
43. RizzoM, ThiererJ, FrancesiaA, BettatiMI, TernsPP, et al. (2004) Registro Nacional de Internación por Insuficiencia Cardíaca 2002–2003. Rev Argent Cardiol 72: 333–340.
44. FairmanE, ThiererJ, RodríguezL, BlancoP, GuettaJ, et al. (2009) 2007 national registry of admissions due to heart failure. Rev Argent Cardiol 77: 33–39.
45. GodoyHL, SilveiraJA, SegallaE, AlmeidaDR (2011) Hospitalization and mortality rates for heart failure in public hospitals in São Paulo. Arq Bras Cardiol 97: 402–407.
46. ManginiS, SilveiraFS, SilvaCP, GrativvolPS, SeguroLF, et al. (2007) Decompensated heart failure in the emergency department of a cardiology hospital. Arq Bras Cardiol 90: 400–406.
47. JafaryFH, KumarM, ChandnaIE (2007) Prognosis of hospitalized new-onset systolic heart failure in Indo-Asians—a lethal problem. J Card Fail 13: 855–860 doi:10.1016/j.cardfail.2007.07.005
48. BahajAA (2010) Clinical characteristic and in-patients mortality among 100 patients with heart failure admitted to Ibn Seena Central Hospital. Iraqi J Med Sci 8: 60–68.
49. ErginA, KemalEN, ÜnalŞ, AbdullahD, SeyfeliE (2004) Epidemiological and pharmacological profile of congestive heart failure at Turkish academic hospitals. Anadolu Kardiyol Derg 4: 32–38.
50. ChioncelO, VinereanuD, DatcuM, IonescuDD, CapalneanuR, et al. (2011) The Romanian Acute Heart Failure Syndromes (RO-AHFS) registry. Am Heart J 162: 142–53.e1 doi:10.1016/j.ahj.2011.03.033
51. ZdrengheaD, PopD, PenciuO, ZdrengheaM (2009) Drug treatment of heart failure patients in a general Romanian hospital. Rom J Intern Med 47: 227–233.
52. LaothavornP, HengrussameeK (2010) Thai Acute Decompensated Heart Failure Registry (Thai ADHERE). CVD Prev 5: 89–95 doi:10.1016/j.cvdpc.2010.06.001
53. ShiC, WangL, HuD, LiJ, ZhuT, et al. (2010) Prevalence, clinical characteristics and outcome in patients with chronic heart failure and diabetes. Chin Med J (Engl) 123: 646–650.
54. WeiL, SuY, FuL, ZhuZ-Y, LuG-L, et al. (2010) Analysis of multiple etiological factors and type of chronic heart failure in elderly patients. Med J Natl Defend Forces Southwest China 20: 259–261.
55. SunX-Q, LiuS-L, LangY-J, SuiY-Y, FuY, et al. (2009) Retrospective analysis of inpatients with heart failure in rural areas of Liaoning province. J China Med Univ 38: 852–854.
56. LiS-Y, SongF-F, ChenH-J (2007) Clinical analysis of 259 senile heart failure inpatients in tropical zone. China Trop Med 7: 1169–1171.
57. Kang'AnC (2002) Retrospective investigation of hospitalised patients with heart failure in some parts of China in 1980, 1990 and 2000. Chin J Cardiol 30: 450–454.
58. AnF, WangL, YangY (2010) Retrospective analysis of medication treatment in 2458 patients with chronic heart failure. Chin J Prev Control Chronic Non-Commun Dis 18: 606–608.
59. Dos ReisFB, FernandesAMS, De AndradeG, BitencourtA, NevesF, et al. (2012) Influencia de la etiologia sobre la mortalidad en la insuficiencia cardiaca con funcion sistolica preservada en una poblacion con alta prealencia de cardiopatia chagascia. Rev Argent Cardiol 81: 246–250 doi:10.7775/rac.es.v81.i3.1417
60. FuS-H, ZhuB, ZhangY-X, YiS-Y, LiuY, et al. (2012) Chronic kidney disease: an independent risk factor of all-cause mortality for elderly Chinese patients with chronic heart failure. J Geriatr Cardiol 9: 355–360 doi:10.3724/SP.J.1263.2012.04121
61. StanojevićD, ApostolovićS, Janković-TomaševićR, Šalinger-MartinovićS, PavlovićM, et al. (2012) Prevalence of renal dysfunction and its influence on functional capacity in elderly patients with stable chronic heart failure. Vojn Pregl 69: 840–845.
62. SunX, LiJ, LangY, SuiY, FuY, et al. (2009) Investigation of epidemiologic features and treatment of chronic heart failure in some rural parts of Liaoning province. Zhongguo Shiyong Neike Zazhi 29: 1000–1002.
63. DegertekinM, ErolC, ErgeneO, TokgozogluL, AksoyM, et al. (2012) [Heart failure prevalence and predictors in Turkey: HAPPY study.]. Turk Kardiyol Dern Ars 40: 298–308 doi: 10.5543/tkda.2012.65031
64. ClelandJGF, Cohen-SolalA, AguilarJC, DietzR, EastaughJ, et al. (2002) Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 360: 1631–1639.
65. BarrettoAC, NobreMR, WajngartenM, CanesinMF, BallasD, et al. (1998) Insuficiência cardíaca em grande hospital terciário de São Paulo. Arq Bras Cardiol 71: 15–20.
66. BarrettoAC, WajngartenM, Serro-AzulJB, PierriH, NussbacherA, et al. (1997) Tratamento medicamentoso de insuficiência cardíaca em hospital terciário de São Paulo. Arq Bras Cardiol 69: 375–379.
67. NogueiraPR, RassiS, CorrêaKDS (2010) Epidemiological, clinical e therapeutic profile of heart failure in a tertiary hospital. Arq Bras Cardiol 95: 392–398.
68. AthertonJJ, HaywardCS, Wan AhmadWA, KwokB, JorgeJ, et al. (2012) Patient characteristics from a regional multicenter database of acute decompensated heart failure in Asia Pacific (ADHERE International-Asia Pacific). J Card Fail 18: 82–88 doi:10.1016/j.cardfail.2011.09.003
69. Roa M, Kadam S, Sathyanarayana TN, Shidhaye R, Shidhaye R, et al. (2009) A rapid evaluation of the Rajiv Aarogyasri community health insurance scheme, Andhra Pradesh. Hyderabad: Indian Institute of Public Health.
70. Magaña-SerranoJA, AlmahmeedW, GomezE, Al-ShamiriM, AdgarD, et al. (2011) Prevalence of heart failure with preserved ejection fraction in Latin American, Middle Eastern, and North African Regions in the I PREFER study (Identification of Patients With Heart Failure and PREserved Systolic Function: an epidemiological regional study). Am J Cardiol 108: 1289–1296 doi:10.1016/j.amjcard.2011.06.044
71. McKeePA, CastelliWP, McNamaraPM, KannelWB (1971) The natural history of congestive heart failure: the Framingham study. N Engl J Med 285: 1441–1446 doi:10.1056/NEJM197112232852601
72. CarlsonKJ, LeeDC-S, GorollAH, LeahyM, JohnsonRA (1985) An analysis of physicians' reasons for prescribing long-term digitalis therapy in outpatients. J Chronic Dis 38: 733–739 doi:10.1016/0021-9681(85)90115-8
73. MoscavitchS-D, GarciaJL, RosaLF, PestanaPR, MoraesLV, et al. (2009) Insuficiência cardíaca: estarão as diretrizes incorporadas na rede de cuidados primários? Rev Port Cardiol 28: 683–696.
74. Brazil Minister of Health (2014) Datasus [database]. Available: http://www2.datasus.gov.br/DATASUS/index.php. Accessed 7 December 2013.
75. SliwaK, WilkinsonD, HansenC, NtyintyaneL, TibazarwaK, et al. (2008) Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet 371: 915–922.
76. NieminenMS, BrutsaertD, DicksteinK, DrexlerH, FollathF, et al. (2006) EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 27: 2725–2736 doi:10.1093/eurheartj/ehl193
77. AdamsKF, FonarowGC, EmermanCL, LeJemtelTH, CostanzoMR, et al. (2005) Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149: 209–216 doi:10.1016/j.ahj.2004.08.005
78. KhatibzadehS, FarzadfarF, OliverJ, EzzatiM, MoranA (2012) Worldwide risk factors for heart failure: A systematic review and pooled analysis. Int J Cardiol 168: 1186–1194 doi:10.1016/j.ijcard.2012.11.065
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2014 Číslo 8
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Nech brouka žít… Ať žije astma!
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
Najčítanejšie v tomto čísle
- Women's Access and Provider Practices for the Case Management of Malaria during Pregnancy: A Systematic Review and Meta-Analysis
- Observational Studies: Getting Clear about Transparency
- Heart Failure Care in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis
- Scaling up Rural Sanitation in India